'Statins for all' – and billions for drug firms

Prescribing them to the healthy may not have saved lives, but it certainly made money

Back in 1975, Henry Gadsden, the chief executive of the drug company Merck, expressed his frustration that the market for his company's products was limited to those with some treatable illness. Ideally, he said, he would like to "sell to everyone".

Three decades later, his dream would seem to have come true – epitomised by the most profitable class of drugs ever discovered, the cholesterol-lowering statins that are taken by an estimated seven million people in Britain, and tens of millions worldwide.　
　
www.telegraph.co.uk/health/8270156/Statins-for-all-and-billions-for-drug-firms.html

Please check out our website at http://www.lowcarbdiabetic.co.uk/